Detalhe da pesquisa
1.
Vector Strategies to Actualize B Cell-Based Gene Therapies.
J Immunol
; 207(3): 755-764, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321286
2.
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy.
J Cell Mol Med
; 26(3): 940-944, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014164
3.
Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges.
Cancers (Basel)
; 13(12)2021 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201007
4.
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma.
Sci Rep
; 11(1): 19343, 2021 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34588522
5.
Nanoparticle T cell engagers for the treatment of acute myeloid leukemia.
Oncotarget
; 12(19): 1878-1885, 2021 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34548905
6.
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance.
Leuk Lymphoma
; 62(10): 2457-2465, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993837
7.
Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile.
Int J Radiat Oncol Biol Phys
; 109(5): 1483-1494, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253820